Chapter 1 mRNA Vaccines & Therapeutics Market Overview
1.1 mRNA Vaccines & Therapeutics Definition
1.2 Global mRNA Vaccines & Therapeutics Market Size Status and Outlook (2018-2032)
1.3 Global mRNA Vaccines & Therapeutics Market Size Comparison by Region (2018-2032)
1.4 Global mRNA Vaccines & Therapeutics Market Size Comparison by Type (2018-2032)
1.5 Global mRNA Vaccines & Therapeutics Market Size Comparison by Application (2018-2032)
1.6 Global mRNA Vaccines & Therapeutics Market Size Comparison by Sales Channel (2018-2032)
1.7 mRNA Vaccines & Therapeutics Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Merger/Acquisition/Expansion)
1.7.4 Key Trends in mRNA Vaccines & Therapeutics Market
Chapter 2 mRNA Vaccines & Therapeutics Market Competition by Player
2.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Player (2021-2023)
2.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Player (2021-2023)
2.3 Global mRNA Vaccines & Therapeutics Average Price by Player (2021-2023)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 mRNA Vaccines & Therapeutics Market Segment by Type
3.1 Global mRNA Vaccines & Therapeutics Market by Type
3.1.1 Standardization of Cancer Treatment MRNA Vaccine
3.1.2 Individualized Cancer Treatment MRNA Vaccine
3.1.3 Infectious Disease Treatment MRNA Vaccine
3.1.4 Infection Prevention MRNA Vaccine
3.2 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2018-2023)
3.3 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2018-2023)
3.4 Global mRNA Vaccines & Therapeutics Average Price by Type (2018-2023)
3.5 Conclusion of Segment by Type
Chapter 4 mRNA Vaccines & Therapeutics Market Segment by Application
4.1 Global mRNA Vaccines & Therapeutics Market by Application
4.1.1 Infectious Disease
4.1.2 Cancer
4.1.3 Other
4.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2018-2023)
4.3 Conclusion of Segment by Application
Chapter 5 mRNA Vaccines & Therapeutics Market Segment by Sales Channel
5.1 Global mRNA Vaccines & Therapeutics Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Sales Channel (2018-2023)
5.3 Conclusion of Segment by Sales Channel
Chapter 6 mRNA Vaccines & Therapeutics Market Segment by Region & Country
6.1 Global mRNA Vaccines & Therapeutics Market Size and CAGR by Region (2018-2032)
6.2 Global mRNA Vaccines & Therapeutics Sales and Market Share by Region (2018-2023)
6.3 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Region (2018-2023)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America mRNA Vaccines & Therapeutics Market Share by Type
6.4.3 North America mRNA Vaccines & Therapeutics Market Share by Application
6.4.4 United States
6.4.5 Canada
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe mRNA Vaccines & Therapeutics Market Share by Type
6.5.3 Europe mRNA Vaccines & Therapeutics Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Spain
6.5.9 Russia
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific mRNA Vaccines & Therapeutics Market Share by Type
6.6.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America mRNA Vaccines & Therapeutics Market Share by Type
6.7.3 South America mRNA Vaccines & Therapeutics Market Share by Application
6.7.4 Brazil
6.7.5 Mexico
6.7.6 Argentina
6.7.7 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa mRNA Vaccines & Therapeutics Market Share by Type
6.8.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Share by Application
6.8.4 Turkey
6.8.5 UAE
6.8.6 Saudi Arabia
6.8.7 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading mRNA Vaccines & Therapeutics Players
7.1 Moderna Therapeutics
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 CureVac
7.3 Translate Bio
7.4 BioNTech
7.5 Sangamo Therapeutics
7.6 Argos Therapeutics
7.7 In-Cell-Art
7.8 eTheRNA
7.9 Ethris
7.10 Tiba Biotechnology
Chapter 8 Upstream and Downstream Analysis of mRNA Vaccines & Therapeutics
8.1 Industrial Chain of mRNA Vaccines & Therapeutics
8.2 Upstream of mRNA Vaccines & Therapeutics
8.3 Downstream of mRNA Vaccines & Therapeutics
Chapter 9 Development Trend of mRNA Vaccines & Therapeutics (2024-2032)
9.1 Global mRNA Vaccines & Therapeutics Market Size (Sales and Revenue) Forecast (2024-2032)
9.2 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Region (2024-2032)
9.3 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Type (2024-2032)
9.4 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Application (2024-2032)
9.5 Global mRNA Vaccines & Therapeutics Market Size and CAGR Forecast by Sales Channel (2024-2032)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
